Pacific Biosciences of California, Inc., based in Menlo Park, specializes in advanced sequencing solutions aimed at unraveling complex genetic information. The company's innovative offerings include sequencing systems, consumable products like SMRT technology for long-read sequencing, and various reagent kits for DNA library preparation. Pacific Biosciences serves a diverse clientele, including research institutions, commercial labs, and pharmaceutical companies, leveraging its global sales force and distribution network. Its commitment to understanding genetic diseases is underscored by partnerships with entities like Invitae Corporation and Radboud University Medical.
Merck and Moderna just proved their cancer vaccine works, and the ripple effects reach far beyond either company. Five names stand to collect a toll on every single dose manufactured, but not…
Have you thought about adding penny stocks to your portfolio? You may be onto something. That is, as long as you choose the right stock picks. But there are risks to consider too.…
With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for Alphatec.
These companies all had initial public offerings in 2010 and are still public. Their performance since then has ranged from −97% to over 16,000%.
